Evidence map›Paper›PMID 36158923›Full record

ArticleWorld journal of hepatology2022

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis.

Vladimir Ivashkin, Albina Ismailova, Ksenia Dmitrieva, Roman Maslennikov, Maria Zharkova, Salekh Aliev, Vyacheslav Bakhitov, Vadim Marcinkevich

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vladimir IvashkinDepartment of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
Albina IsmailovaDepartment of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
Ksenia DmitrievaDepartment of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
Roman MaslennikovDepartment of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
Maria ZharkovaDepartment of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
Salekh AlievAdministration, Consultative and Diagnostic Center № 2 of Department of Health, Moscow 107764, Russia.
Vyacheslav BakhitovAdministration, Consultative and Diagnostic Center № 2 of Department of Health, Moscow 107764, Russia.
Vadim MarcinkevichAdministration, Consultative and Diagnostic Center № 2 of Department of Health, Moscow 107764, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis have not been evaluated yet.

aimTo evaluate the clinical efficacy and safety of vaccination against COVID-19 in patients with cirrhosis.

methodsThis was a retrospective cohort study of patients with cirrhosis. The first cohort included patients vaccinated with Gam-COVID-Vac (Sputnik V); the second one consisted of unvaccinated controls.

resultsThe study included 89 vaccinated patients and 148 unvaccinated ones. There were 4 cases of COVID-19 in the vaccinated group and 24 cases in the unvaccinated group (

conclusionVaccination against COVID-19 in patients with cirrhosis is effective and safe.

Indexed as

BoosterCoronavirusRevaccinationSARS-CoV-2Sputnik VVaccination

Identifiers

PMID36158923
PMCPMC9376781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.